Impact of mirabegron versus solifenacin on autonomic function and arterial stiffness in female overactive bladder syndrome: a randomized controlled trial.

Hsiao SM, Tu FC, Su TC, Wu PC, Lin HH.

Open source

DOI
10.1038/s41598-022-18391-6
Published
2022-08-20
Container
Sci Rep
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-022-18391-6,
  title = {Impact of mirabegron versus solifenacin on autonomic function and arterial stiffness in female overactive bladder syndrome: a randomized controlled trial.},
  author = {Hsiao SM and  Tu FC and  Su TC and  Wu PC and  Lin HH.},
  year = {2022},
  journal = {Sci Rep},
  doi = {10.1038/s41598-022-18391-6},
  url = {https://doi.org/10.1038/s41598-022-18391-6}
}

RIS

TY  - JOUR
TI  - Impact of mirabegron versus solifenacin on autonomic function and arterial stiffness in female overactive bladder syndrome: a randomized controlled trial.
AU  - Hsiao SM
AU  -  Tu FC
AU  -  Su TC
AU  -  Wu PC
AU  -  Lin HH.
PY  - 2022
JO  - Sci Rep
DO  - 10.1038/s41598-022-18391-6
UR  - https://doi.org/10.1038/s41598-022-18391-6
ER  - 

APA

SM, H., FC, T., TC, S., PC, W., & HH., L. (2022). Impact of mirabegron versus solifenacin on autonomic function and arterial stiffness in female overactive bladder syndrome: a randomized controlled trial.. Sci Rep. https://doi.org/10.1038/s41598-022-18391-6

Source records